Biotech Analyst Tsai, along with Key Opinion Leader, Dr. Amy Chi, discuss Ligand Pharmaceuticals’ partner, Verona Pharma’s, Ohtuvayre, a new inhaled treatment for Chronic Obstructive Pulmonary Disease (COPD) on an Analyst/Industry conference call to be held on September 12 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGND:
Questions or Comments about the article? Write to editor@tipranks.com